Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2020 Financial Results on August 10, 2020

Rhea-AI Summary

Organogenesis Holdings Inc. (Nasdaq: ORGO) has scheduled its second quarter 2020 financial results announcement for August 10, 2020, after market close. A conference call will follow at 5:00 p.m. ET, providing updates and a question and answer session. Investors can join by dialing 866-795-3142 or via a live webcast on the company’s investor relations website. A replay will be available for two weeks. Organogenesis specializes in regenerative medicine products for Advanced Wound Care and Surgical markets.

CANTON, Mass., June 29, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that second quarter of fiscal year 2020 financial results will be reported after the market closes on Monday, August 10.

Management will host a conference call at 5:00 p.m. Eastern Time on August 10 to discuss the results of the quarter and provide a corporate update with a question and answer session. Those who would like to participate may dial 866-795-3142 (409-937-8908 for international callers) and provide access code 4153175. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.organogenesis.com.

For those unable to participate, a replay of the call will be available for two weeks at 855-859-2056 (404-537-3406 for international callers); access code 4153175. The webcast will be archived at investors.organogenesis.com.

About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs. For more information, visit www.organogenesis.com.

 

FAQ

When will Organogenesis report its second quarter financial results for 2020?

Organogenesis will report its second quarter financial results on August 10, 2020, after market close.

What time is the conference call for Organogenesis's financial results?

The conference call will be held at 5:00 p.m. Eastern Time on August 10, 2020.

How can I access the conference call for Organogenesis?

You can access the conference call by dialing 866-795-3142 or by visiting the company’s investor relations website for a live webcast.

Is there a replay available for the Organogenesis conference call?

Yes, a replay of the call will be available for two weeks at 855-859-2056.